BenzingaOctober 22, 2026 at 5:31 AM NY5 Days Ago
TD Cowen Maintains Buy on Abbott Laboratories, Lowers Price Target to $118
TD Cowen analyst Joshua Jennings maintains Abbott Laboratories (NYSE:ABT) with a Buy and lowers the price target from $135 to $118.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
